Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-02-07
2006-02-07
Saoud, Christine J. (Department: 1647)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S325000, C435S243000, C435S320100, C536S023500
Reexamination Certificate
active
06994989
ABSTRACT:
A protein designated flk-1bp binds the vascular endothelial cell surface receptor flk-1. Isolated DNA encoding flk-1bp is provided, along with expression vectors and transformed host cells useful in producing flk-1bp polypeptides. Antibodies that are immunoreactive with flk-1bp are generated using the polypeptides disclosed herein.
REFERENCES:
patent: 5185438 (1993-02-01), Lemischka
patent: 5283354 (1994-02-01), Lemischka
patent: 5607918 (1997-03-01), Eriksson et al.
patent: 5935820 (1999-08-01), Hu et al.
patent: 6040157 (2000-03-01), Hu et al.
patent: 6245530 (2001-06-01), Alitalo et al.
patent: 6451764 (2002-09-01), Lee et al.
patent: 0 506 477 (1992-09-01), None
patent: WO 92/14748 (1992-09-01), None
patent: WO 94/11499 (1994-05-01), None
patent: WO 95/21865 (1995-08-01), None
patent: WO 95/24473 (1995-09-01), None
patent: WO 96/26736 (1996-09-01), None
patent: WO 96/27007 (1996-09-01), None
patent: WO 96/39515 (1996-12-01), None
patent: WO 97/05250 (1997-02-01), None
patent: WO 97/09427 (1997-03-01), None
Lee et al., “Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4”,Proc. Natl. Acad. Sci. USA 93:1988-1992, 1996.
Joukov et al., “A Novel Vascular Endothelial Growth Factor, VEGF-C, is a Ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) Receptor Tyrosine Kinases”,EMBO J. 15:290-298, 1996.
Joukov et al., “A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3)and KDR (VEGFR-2) receptor tyrosine kinases”,EMBO J. 15:1751, 1996.
Printout of databank record for NCBI accession No. Z44272, Nov. 6, 1994.
Printout of databank record for accession No. X94216, Feb. 6, 1996.
Printout of databank record for accession No. U43142, Jan. 10, 1996.
Lyttle et al., “Homologs of Vascular Endothelial Growth Factor Are Encoded by the Poxvirus Orf Virus”,J. Virol. 68:84-92, 1994.
Olofsson et al., “Vascular endothelial growth factor B, a novel growth factor for endothelial cells”,Proc. Natl. Acad. Sci. USA 93:2576-2581, 1996.
Grimmond et al., “Cloning and Characterization of a Novel Human Gene Related to Vascular Endothelial Growth Factor”,Genome Research 6:124-131, 1996.
Terman et al., “Identification of a new endothelial cell growth factor receptor tyrosine kinase”,Oncogene 6:1677-1683, 1991.
Sarzani et al., “A Novel Endothelial Tyrosine Kinase cDNA Homologous to Platelet-Derived Growth Factor Receptor cDNA”,Biochem. Biophys. Res. Comm. 186:706-714, 1992.
Matthews et al., “A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage toc-kit”, Proc. Natl. Acad. Sci. USA 88:9026-9030, 1991.
Terman et al., “Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor”,Biochem. Biophys. Res. Comm. 187:1579-1586, 1992.
Millauer et al., “High Affinity VEGF Binding and Developmental Expression Suggest Flk-1 as a Major Regulator of Vasculogenesis and Angiogenesis”,Cell 72:835-846, 1993.
Galland et al., “TheFLT4gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor”,Oncogene8:1233-1240, 1993.
Pajusola et al., “Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts”,Oncogene 8:2931-2937, 1993.
Pajusola et al., “Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors”,Oncogene 9:3545-3555, 1994.
Kaipainen et al., “Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development”,Proc. Natl. Acad. Sci. USA 92:3566-3570, 1995.
Mustonen and Alitalo, “Endothelial Receptor Tyrosine Kinases Involved in Angiogenesis”,J. Cell Biol. 129:895-898, 1995.
De Vries et al., “Thefms-Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor”,Science 255:989-991, 1992.
Yamaguchi et al., “flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors”,Development 118:489-498, 1993.
Ferrara et al., “The Vascular Endothelial Growth Factor Family of Polypeptides,”J. Cellular Biochemistry 47:211-218, 1991.
Printout of databank record for accession No. N42368, Jan. 25, 1996.
Printout of databank record for accession No. N42374, Jan. 25, 1996.
Bellas Christine M.
Immunex Corp.
Saoud Christine J.
LandOfFree
FLK-1 binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FLK-1 binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FLK-1 binding proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3637561